Pfizer Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 18,238.0 | 13,353.0 | 17,594.0 |
| Net Investing Cash Flow | (12,835.0) | 795.0 | 5,101.0 |
| Net Financing Cash Flow | (6,560.0) | (12,610.0) | (23,100.0) |
| Net Change in Cash | (1,284.0) | 1,579.0 | (420.0) |
| Depreciation & Amortization | 2,668.0 | 3,128.0 | 3,261.0 |
| Capital Expenditures | (1,701.0) | (1,880.0) | (2,050.0) |
| Cash Dividends Paid | (8,541.0) | (7,975.0) | (6,919.0) |
© 2009 Morningstar, Inc. Financial Data provided by
